Aeglea Biotherapeutics's competitors

Aeglea Biotherapeutics's competitors include ImmunoGen, Heat Biologics, XBiotech and Geron Corporation
Add company...
Aeglea Biotherapeutics
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.
ImmunoGen
ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology.
Heat Biologics
Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.
XBiotech
XBiotech is a biopharmaceutical company developing first-in-class antibody therapies.
Geron Corporation
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Founding Date
Founding Date
2013
Founding Date
1981
Founding Date
2008
Founding Date
2005
Founding Date
1990
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Austin, US HQ
Locations
Waltham, US HQ
Norwood, US
Brentwood, US
Locations
Durham, US HQ
Locations
Austin, US HQ
Locations
Menlo Park, US HQ
Canton, US
Employees
Employees
45 18% increase
Employees
308
Employees
19
Employees
56
Employees
15
Valuation ($)
Valuation ($)
99.8 m
Valuation ($)
982.3 m
Valuation ($)
11.6 m
Valuation ($)
166.1 m
Valuation ($)
378.9 m
Facebook followers
Facebook followers
N/A
Facebook followers
N/A
Facebook followers
111
Facebook followers
187
Facebook followers
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
387
Twitter followers
N/A
Twitter followers
160
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$60m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$6.2m (FY, 2016)
Net income
Net income
($21.7m) (FY, 2016)
Net income
($144.8m) (FY, 2016)
Net income
($13m) (FY, 2016)
Net income
($50.7m) (FY, 2016)
Net income
($29.5m) (FY, 2016)
For sources of this data, please see the company profileDownload Excel

View company profiles